Back to News
Market Impact: 0.05
Silo Pharma To Highlight SPC-15 Nose-To-Brain Technology At 2026 Nasal Innovation Forum
Source: Nasdaq
Healthcare & Biotech
Silo Pharma announced that its representatives will participate in the IPAC-RS 2026 Nasal Innovation Forum on September 16-17 in Jersey City, New Jersey. The event-participation announcement includes no clinical, financial, regulatory, or commercial update and is unlikely to materially affect the shares.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
SILO0.10
More News
- Nano-X Imaging (NNOX) Q2 2026 Earnings Call Transcript
- Chewy (CHWY) Q2 2026 Earnings Call Transcript
- Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm to Learn About Their Legal Rights
- RNC Day 1 Kicks off in Dallas
- Kaplan Fox is Investigating Possible Securities Law Violations against Alignment Healthcare, Inc. (NASDAQ: ALHC)
- Xenon at wells fargo healthcare conference: azetukalner launch nears